Feature

OS Therapies aims to activate the immune system to combat aggressive cancers in human and canine patients

OS Therapies (NYSE American: OSTX) is addressing the urgent need for innovative therapies to kill aggressive cancers that express HER2, including osteosarcoma—a rare and often fatal bone cancer—as well as other solid...

June 16, 2026

Feature

Healing the Hero rewiring trauma through neurolinguistic programming

The nonprofit organization Healing the Hero is bringing hope to U.S. military personnel, veterans, first responders, and Gold Star Families by leveraging neurolinguistic programming (NLP)-informed methods to directly...

June 9, 2026

Feature

Siloton further unlocking the power of OCT imaging with a groundbreaking photonic chip

Closely held Siloton is developing a patented miniaturized medical imaging platform that combines photonic chips with optical coherence tomography (OCT) to detect and monitor a range of prevalent ophthalmic diseases...

June 2, 2026

Feature

Pacylex reshaping cancer treatment with a novel once-daily oral therapy

Closely held Pacylex Pharmaceuticals is developing a first-in-class oral cancer therapy with a novel, broad mechanism of action designed for refractory cancers as both a monotherapy and a future combination therapy.

May 26, 2026

NEWS

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

OS Therapies aims to activate the immune system to combat aggressive cancers in human and canine patients

Healing the Hero rewiring trauma through neurolinguistic programming

Siloton further unlocking the power of OCT imaging with a groundbreaking photonic chip

Pacylex reshaping cancer treatment with a novel once-daily oral therapy

NEWS

Microbot signs agreement with Lovell expanding access to veteran and military populations

Entera reports robust data for pipeline programs in HypoPT and obesity

E.F. Hutton appoints healthcare investment banking veteran Bryan Kobel as managing director

Dr. Jeff Coller joins 4basebio’s SAB

Faron unveils immunotherapy data in myeloid malignancies at EHA

Context reports positive data for CTIM-76 in PROC

Evaxion presents new data for off-the-shelf AML vaccine

60 Degrees signs licensing agreement with Florida State for botanical supplement

Caribou reports long-term vispa-cel data in r/r B-NHL

Just a few of the companies we’ve highlighted along the way

Subscribe